Dr. Gary Schummer spent 35 years treating ADHD with neurofeedback โ€” so when a major study concluded neurofeedback was "no better than placebo," he sat down and took it apart. This week he joins host Pete Jansons and Joshua Moore (MA, LMHC, BCN) to explain why he believes the study's "placebo" group wasn't a placebo at all, but a second active treatment โ€” which changes what that headline result actually means.


From there the conversation goes deeper than one paper: Barry Sterman's NASA cat studies and why animals can't fake a placebo effect, Gary's account of helping hundreds of children reduce or discontinue medication, the epilepsy data that still gets ignored, and the panel's debate over insurance, reimbursement and treatment incentives. Then it turns inward โ€” Gary admits neurofeedback has no agreed standards of care and no shared training curriculum, and Pete makes a pledge on camera to help fix it. "We start today."


๐ŸŽ™๏ธ Panel: Dr. Gary Schummer (35-year clinical neurofeedback; author of the 2024 NeuroRegulation critique) and Joshua Moore (MA, LMHC, BCN โ€” Neurofeedback Care) โ€” host Pete Jansons.


๐Ÿง  WHAT WE COVER:

๐Ÿง  0:00 โ€” "They didn't have a placebo group": the cold open

๐Ÿ‘‹ 0:56 โ€” Welcome: Gary Schummer & Joshua Moore

๐Ÿ“„ 1:50 โ€” The two ADHD studies & Gary's JAACAP critique

๐Ÿ’Š 3:13 โ€” Why is neurofeedback held to pharma's standard?

๐ŸŽ“ 5:35 โ€” How Gary found neurofeedback โ€” meeting Barry Sterman

๐Ÿฅ 8:09 โ€” 35 years in practice, specializing in ADD

๐Ÿ‘ด 10:07 โ€” Barry Sterman: father of clinical neurofeedback

๐Ÿš€ 11:22 โ€” NASA, jet fuel and the cats

๐Ÿฑ 14:35 โ€” The SMR-trained cats that resisted seizures

๐Ÿ”ฌ 17:31 โ€” Why cats can't have a placebo effect

๐Ÿ’ฐ 19:52 โ€” Insurance, incentives & why neurofeedback got sidelined

โœ๏ธ 20:20 โ€” Why Gary wrote the critique

๐Ÿง  21:10 โ€” Gary on getting kids off medication

๐Ÿ“Š 23:03 โ€” Sterman's 2000 epilepsy meta-analysis

๐ŸŽฏ 28:11 โ€” Gary's core argument against the Arnold study

โŒ 29:54 โ€” Not a placebo โ€” another treatment group

๐Ÿ… 32:56 โ€” From the back of the room to most-improved

๐Ÿ” 33:31 โ€” Cure vs. remission

๐Ÿงฉ 39:58 โ€” Neurofeedback's standards problem

๐Ÿ“– 40:54 โ€” No agreed training curriculum

๐Ÿ›๏ธ 45:42 โ€” "Why isn't there a board?"

๐Ÿ™Œ 50:01 โ€” Pete's pledge: "We start today"

๐Ÿ’ต 52:55 โ€” $180 vs $60: the economics of access

๐Ÿง  59:50 โ€” Should kids get a brain baseline?


๐Ÿ”— Updates & Links:

๐Ÿ“„ Gary Schummer โ€” 2024 NeuroRegulation critique: https://www.neuroregulation.org/artic...

๐Ÿงฉ Joshua Moore โ€” Neurofeedback Care: https://neurofeedbackcare.com


โš ๏ธ Educational content only โ€” not medical advice.


๐Ÿ’ช Help keep NeuroNoodle Neurofeedback Therapy Podcast going!

๐Ÿ‘‰ Support on Patreon: / neuronoodle

๐Ÿ”” Like, subscribe, share & hit the bell for weekly episodes

Podden och tillhรถrande omslagsbild pรฅ den hรคr sidan tillhรถr Pete Jansons. Innehรฅllet i podden รคr skapat av Pete Jansons och inte av, eller tillsammans med, Poddtoppen.